Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-30
1997-12-09
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544268, 544270, A61K 3152, C07D47300
Patent
active
056961243
ABSTRACT:
The invention relates to new xanthine derivatives of general formula I, processes for preparing them and their use as pharmaceutical compositions.
REFERENCES:
patent: 3624216 (1971-11-01), Stein
patent: 4548939 (1985-10-01), Kennis et al.
patent: 4584372 (1986-04-01), Venero et al.
patent: 4622324 (1986-11-01), Klessing et al.
patent: 4755517 (1988-07-01), Bruns et al.
Jacobson et al., J. Med. Chem., 35, No. 3., 1992 Perspective 1 Page (407) Cecil., Textbook of Medicine., 19th Edn 1992, p. 2077.
Ensinger Helmut
Kufner-Muhl Ulrike
Kuhn Franz Josef
Lehr Erich
Schingnitz Gunter
Boehringer Ingelheim KG
Devlin Mary Ellen
Raymond Robert P.
Shah Mukund J.
Sripada Pavanaram K.
LandOfFree
Xanthine derivatives with adenosine-antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives with adenosine-antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives with adenosine-antagonistic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1607907